IBRX Stock Forecast & Price Target
IBRX Stock
Price Forecast
The average stock forecast for
Immunitybio Inc (IBRX) in the next 12 months is 13.01 USD. This price target corresponds to an upside
of
58.79%. The range of stock forecasts for IBRX is 12.12 - 15.75 USD.
Based on the ratings of 10 analysts, the consensus recommendation for IBRX is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
12.12 |
13.01 |
12.24 |
15.75 |
| Upside |
47.99% |
58.79% |
49.45% |
92.31% |
Recommendation Trends
The latest consensus rating for IBRX is "BUY". This is the average
recommendation of 10 analysts: 0 strong sell,
0 sell, 1 hold, 5 buy, 4 strong buy. In the previous period, 10 analysts also majorly recommmended
"BUY" for IBRX.
IBRX Financial Stock
Forecast
Revenue This Year
from 113.29M
Revenue Next Year
from 232.97M